{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T16:23:48Z","timestamp":1785860628131,"version":"3.56.0"},"reference-count":33,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,9,11]],"date-time":"2020-09-11T00:00:00Z","timestamp":1599782400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2020.02057","type":"journal-article","created":{"date-parts":[[2020,9,11]],"date-time":"2020-09-11T04:38:13Z","timestamp":1599799093000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":22,"title":["Antigenic Variability"],"prefix":"10.3389","volume":"11","author":[{"given":"Alexander I.","family":"Mosa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,9,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1128\/MMBR.05023-11","article-title":"Viral quasispecies evolution","volume":"76","author":"Domingo","year":"2012","journal-title":"Microbiol Mol Biol Rev."},{"key":"B2","doi-asserted-by":"publisher","first-page":"2640","DOI":"10.1080\/21645515.2016.1191718","article-title":"Antigenic variability: obstacles on the road to vaccines against traditionally difficult targets","volume":"12","author":"Serv\u00edn-Blanco","year":"2016","journal-title":"Hum Vaccin Immunother."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-019-49454-w","article-title":"Clearance of hepatitis C, virus is associated with early and potent but narrowly-directed, Envelope-specific antibodies","volume":"9","author":"Walker","year":"2019","journal-title":"Scient Rep."},{"key":"B4","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.coviro.2013.05.008","article-title":"To dream the impossible dream: universal influenza vaccination","volume":"3","author":"Yewdell","year":"2013","journal-title":"Curr Opin Virol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.3390\/v2122649","article-title":"The complexity of antibody-dependent enhancement of dengue virus infection","volume":"2","author":"Guzman","year":"2010","journal-title":"Viruses."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.1002\/hep.28760","article-title":"Hepatitis C virus plays hide and seek with neutralizing antibodies","volume":"64","author":"Bankwitz","year":"2016","journal-title":"Hepatology."},{"key":"B7","doi-asserted-by":"publisher","first-page":"6653","DOI":"10.1073\/pnas.1422942112","article-title":"Antigenic cooperation among intrahost HCV variants organized into a complex network of cross-immunoreactivity","volume":"112","author":"Skums","year":"2015","journal-title":"PNAS."},{"key":"B8","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/j.jhep.2016.11.022","article-title":"Post-treatment resistance analysis of hepatitis C virus from phase II, and, I. I I, clinical trials of ledipasvir\/sofosbuvir","volume":"66","author":"Wyles","year":"2017","journal-title":"J Hepatol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"9685","DOI":"10.1073\/pnas.0801774105","article-title":"Coordinated evolution of the hepatitis C virus","volume":"105","author":"Campo","year":"2008","journal-title":"PNAS."},{"key":"B10","doi-asserted-by":"publisher","first-page":"9758","DOI":"10.1128\/JVI.01097-15","article-title":"Similarities between human immunodeficiency virus type 1 and hepatitis c virus genetic and phenotypic protease quasispecies diversity","volume":"89","author":"Martinez","year":"2015","journal-title":"J Virol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"e01685","DOI":"10.1128\/JVI.01685-18","article-title":"Positive selection at key residues in the HIV envelope distinguishes broad strain-specific plasma neutralizing antibodies","volume":"93","author":"Mabvakure","year":"2019","journal-title":"J Virol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"3112","DOI":"10.1128\/JVI.02458-15","article-title":"Antibody response to hypervariable region 1 interferes with broadly neutralizing antibodies to hepatitis C virus","volume":"90","author":"Keck","year":"2016","journal-title":"J Virol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"3995","DOI":"10.3390\/v7072809","article-title":"Genetic diversity underlying the envelope glycoproteins of hepatitis C virus: structural and functional consequences and the implications for vaccine design","volume":"7","author":"Tarr","year":"2015","journal-title":"Viruses."},{"key":"B14","doi-asserted-by":"publisher","first-page":"329","DOI":"10.3389\/fmicb.2014.00329","article-title":"Challenges to the development of vaccines to hepatitis C virus that elicit neutralizing antibodies","volume":"5","author":"Drummer","year":"2014","journal-title":"Front Microbiol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.immuni.2018.11.011","article-title":"Vaccine-Induced Protection from Homologous Tier, 2 S. HIV, challenge in nonhuman primates depends on serum-neutralizing antibody titers","volume":"50","author":"Pauthner","year":"2019","journal-title":"Immunity."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-018-28706-1","article-title":"The influenza virus hemagglutinin head evolves faster than the stalk domain","volume":"8","author":"Kirkpatrick","year":"2018","journal-title":"Sci Rep."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-019-39871-2","article-title":"Predicting seasonal influenza epidemics using cross-hemisphere influenza surveillance data and local internet query data","volume":"9","author":"Zhang","year":"2019","journal-title":"Sci Rep."},{"key":"B18","doi-asserted-by":"publisher","first-page":"344","DOI":"10.3389\/fcimb.2019.00344","article-title":"The quest for a truly universal influenza vaccine","volume":"9","author":"Jang","year":"2019","journal-title":"Front Cell Infect Microbiol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"e03243","DOI":"10.1128\/mBio.03243-19","article-title":"Influenza virus infection induces a narrow antibody response in children but a broad recall response in adults","volume":"11","author":"Meade","year":"2020","journal-title":"mBio."},{"key":"B20","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1146\/annurev-immunol-041015-055515","article-title":"Broadly neutralizing antibodies to HIV and their role in vaccine design","volume":"34","author":"Burton","year":"2016","journal-title":"Annu Rev Immunol."},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0019562","article-title":"Genetic diversity of near genome-wide hepatitis C, virus sequences during chronic infection: evidence for protein structural conservation over time","volume":"6","author":"Li","year":"2011","journal-title":"PLoS ONE"},{"key":"B22","doi-asserted-by":"publisher","first-page":"e01032","DOI":"10.1128\/JVI.01032-17","article-title":"Structure-based design of hepatitis C virus vaccines that elicit neutralizing antibody responses to a conserved epitope","volume":"91","author":"Pierce","year":"2017","journal-title":"J Virol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"910","DOI":"10.3389\/fimmu.2018.00910","article-title":"Glycan shielding and modulation of hepatitis C virus neutralizing antibodies","volume":"9","author":"Lavie","year":"2018","journal-title":"Front Immunol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"518","DOI":"10.4172\/2155-9899.1000518","article-title":"Conserved HIV epitopes for an effective HIV vaccine","volume":"8","author":"Sahay","year":"2017","journal-title":"J Clin Cell Immunol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.coi.2016.05.012","article-title":"Heads, stalks and everything else: how can antibodies eradicate influenza as a human disease?","volume":"42","author":"Neu","year":"2016","journal-title":"Curr Opin Immunol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"197","DOI":"10.3390\/v10040197","article-title":"The hard way towards an antibody-based HIV-1 env vaccine: lessons from other viruses","volume":"10","author":"Ringel","year":"2018","journal-title":"Viruses"},{"key":"B27","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.virol.2010.12.020","article-title":"Antibody-mediated neutralization of flaviviruses: a reductionist view","volume":"411","author":"Dowd","year":"2011","journal-title":"Virology."},{"key":"B28","doi-asserted-by":"publisher","first-page":"14199","DOI":"10.1073\/pnas.2335981100","article-title":"In vitro assay for neutralizing antibody to hepatitis C virus: evidence for broadly conserved neutralization epitopes","volume":"100","author":"Bartosch","year":"2003","journal-title":"PNAS."},{"key":"B29","doi-asserted-by":"publisher","first-page":"e1003840","DOI":"10.1371\/journal.ppat.1003840","article-title":"Overcoming antigenic diversity by enhancing the immunogenicity of conserved epitopes on the malaria vaccine candidate apical membrane antigen-1","volume":"9","author":"Dutta","year":"2013","journal-title":"PLoS Pathog"},{"key":"B30","doi-asserted-by":"publisher","first-page":"212","DOI":"10.4049\/jimmunol.1401054","article-title":"Simulation of B cell affinity maturation explains enhanced antibody cross-reactivity induced by the polyvalent malaria vaccine AMA1 (VAC11P","volume":"194","author":"Chaudhury","year":"2015","journal-title":"J Immunol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"200","DOI":"10.3389\/fcimb.2019.00200","article-title":"Molecular simulations reveal the role of antibody fine specificity and viral maturation state on antibody-dependent enhancement of infection in dengue virus","volume":"9","author":"Ripoll","year":"2019","journal-title":"Front Cell Infect Microbiol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"E102235","DOI":"10.1371\/journal.pone.0102235","article-title":"Hepatitis C, virus hypervariable region 1 variants presented on hepatitis b virus capsid-like particles induce cross-neutralizing antibodies","volume":"9","author":"Lange","year":"2014","journal-title":"PLoS ONE"},{"key":"B33","doi-asserted-by":"publisher","first-page":"274","DOI":"10.3389\/fimmu.2014.00274","article-title":"Protective immunity against hepatitis C: many shades of gray","volume":"5","author":"Abdel-Hakeem","year":"2014","journal-title":"Front Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.02057\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,11]],"date-time":"2020-09-11T04:38:14Z","timestamp":1599799094000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.02057\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,11]]},"references-count":33,"alternative-id":["10.3389\/fimmu.2020.02057"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2020.02057","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,11]]},"article-number":"2057"}}